{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:11:17Z","timestamp":1790727077351,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":256,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1074\/jbc.rev119.006349","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T21:45:26Z","timestamp":1572558326000},"page":"18769-18783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Biological, chemical, and biochemical strategies for modifying glycopeptide antibiotics"],"prefix":"10.1016","volume":"294","author":[{"given":"Edward","family":"Marschall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9739-6157","authenticated-orcid":false,"given":"Max J.","family":"Cryle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0391-2526","authenticated-orcid":false,"given":"Julien","family":"Tailhades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.REV119.006349_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"10.1074\/jbc.REV119.006349_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev"},{"key":"10.1074\/jbc.REV119.006349_bib3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/nbt1266","article-title":"New antibiotics from bacterial natural products","volume":"24","author":"Clardy","year":"2006","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/jbc.REV119.006349_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/1568026616666160713143331","article-title":"Antimicrobial peptides under clinical trials","volume":"17","author":"Greber","year":"2017","journal-title":"Curr. Top. Med. Chem"},{"key":"10.1074\/jbc.REV119.006349_bib5","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1038\/s41598-018-24614-6","article-title":"Emergence of vancomycin-resistant Enterococcus faecium at an Australian hospital: a whole genome sequencing analysis","volume":"8","author":"Leong","year":"2018","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.REV119.006349_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(88)91037-9","article-title":"Vancomycin-resistant enterococci","volume":"331","author":"Uttley","year":"1988","journal-title":"Lancet"},{"key":"10.1074\/jbc.REV119.006349_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis"},{"key":"10.1074\/jbc.REV119.006349_bib8","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/AAC.00346-09","article-title":"VanA-type vancomycin-resistant Staphylococcus aureus","volume":"53","author":"P\u00e9richon","year":"2009","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.REV119.006349_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.mib.2010.08.011","article-title":"Glycopeptide biosynthesis in the context of basic cellular functions","volume":"13","author":"Stegmann","year":"2010","journal-title":"Curr. Opin. Microbiol"},{"key":"10.1074\/jbc.REV119.006349_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cbpa.2012.01.017","article-title":"Combining biocatalysis and chemoselective chemistries for glycopeptide antibiotics modification","volume":"16","author":"Li","year":"2012","journal-title":"Curr. Opin. Chem. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/sb300092n","article-title":"Opportunities for synthetic biology in antibiotics: expanding glycopeptide chemical diversity","volume":"4","author":"Thaker","year":"2015","journal-title":"ACS Synth. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1039\/C1CS15125H","article-title":"Recent advances in the synthesis of new glycopeptide antibiotics","volume":"41","author":"Ashford","year":"2012","journal-title":"Chem. Soc. Rev"},{"key":"10.1074\/jbc.REV119.006349_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ja.2013.117","article-title":"Glycopeptide antibiotic biosynthesis","volume":"67","author":"Yim","year":"2014","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.REV119.006349_bib14","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1039\/C5NP00025D","article-title":"Structural aspects of phenylglycines, their biosynthesis and occurrence in peptide natural products","volume":"32","author":"Al Toma","year":"2015","journal-title":"Nat. Prod. Rep"},{"key":"10.1074\/jbc.REV119.006349_bib15","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1021\/ja001663j","article-title":"Total synthesis of the teicoplanin aglycon","volume":"122","author":"Boger","year":"2000","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib16","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.1021\/ja992577q","article-title":"Total synthesis of the vancomycin aglycon","volume":"121","author":"Boger","year":"1999","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1521-3773(19990115)38:1\/2<240::AID-ANIE240>3.0.CO;2-5","article-title":"Total synthesis of vancomycin","volume":"38","author":"Nicolaou","year":"1999","journal-title":"Angew. Chem. Int. Ed"},{"key":"10.1074\/jbc.REV119.006349_bib18","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1002\/(SICI)1521-3773(19981016)37:19<2700::AID-ANIE2700>3.0.CO;2-P","article-title":"Total syntheses of vancomycin and eremomycin aglycons","volume":"37","author":"Evans","year":"1998","journal-title":"Angew. Chem. Int. Ed"},{"key":"10.1074\/jbc.REV119.006349_bib19","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1021\/ja0572912","article-title":"Total synthesis and evaluation of [\u03a8[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual d-Ala\u2013d-Ala and d-Ala\u2013d-Lac binding","volume":"128","author":"Crowley","year":"2006","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib20","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.1021\/ja302808p","article-title":"Silver(I)-promoted conversion of thioamides to amidines: divergent synthesis of a key series of vancomycin aglycon residue 4 amidines that clarify binding behavior to model ligands","volume":"134","author":"Okano","year":"2012","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1021\/ja209937s","article-title":"Total synthesis of [\u03a8[C(\u03a8S)NH]Tpg4]vancomycin aglycon, [\u03a8[C(\u03a8NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual d-Ala\u2013d-Ala and d-Ala\u2013d-Lac binding","volume":"134","author":"Xie","year":"2012","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib22","doi-asserted-by":"crossref","first-page":"13946","DOI":"10.1021\/ja207142h","article-title":"A redesigned vancomycin engineered for dual d-Ala\u2013d-Ala and d-Ala\u2013d-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria","volume":"133","author":"Xie","year":"2011","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib23","doi-asserted-by":"crossref","first-page":"11952","DOI":"10.1021\/acs.chemrev.6b00820","article-title":"Total syntheses of vancomycin-related glycopeptide antibiotics and key analogs","volume":"117","author":"Okano","year":"2017","journal-title":"Chem. Rev"},{"key":"10.1074\/jbc.REV119.006349_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1039\/C6MB00675B","article-title":"Diversity of nature\u2019s assembly lines\u2013recent discoveries in non-ribosomal peptide synthesis","volume":"13","author":"Payne","year":"2016","journal-title":"Mol. Biosyst"},{"key":"10.1074\/jbc.REV119.006349_bib25","doi-asserted-by":"crossref","first-page":"9834","DOI":"10.1002\/anie.201602614","article-title":"New structural data reveal the motion of carrier proteins in nonribosomal peptide synthesis","volume":"55","author":"Kittil\u00e4","year":"2016","journal-title":"Angew. Chem. Int. Ed"},{"key":"10.1074\/jbc.REV119.006349_bib26","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/anie.201609079","article-title":"Nonribosomal peptide synthesis\u2013principles and prospects","volume":"56","author":"S\u00fcssmuth","year":"2017","journal-title":"Angew. Chem. Int. Ed"},{"key":"10.1074\/jbc.REV119.006349_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1039\/C7NP00063D","article-title":"Unrivalled diversity: the many roles and reactions of bacterial cytochromes P450 in secondary metabolism","volume":"35","author":"Greule","year":"2018","journal-title":"Nat. Prod. Rep"},{"key":"10.1074\/jbc.REV119.006349_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.sbi.2016.05.018","article-title":"Understanding the crucial interactions between cytochrome P450s and non-ribosomal peptide synthetases during glycopeptide antibiotic biosynthesis","volume":"41","author":"Peschke","year":"2016","journal-title":"Curr. Opin. Struct. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature14141","article-title":"X-domain of peptide synthetases recruits oxygenases crucial for glycopeptide biosynthesis","volume":"521","author":"Haslinger","year":"2015","journal-title":"Nature"},{"key":"10.1074\/jbc.REV119.006349_bib30","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1021\/jacs.6b00307","article-title":"Regulation of the P450 oxygenation cascade involved in glycopeptide antibiotic biosynthesis","volume":"138","author":"Peschke","year":"2016","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib31","doi-asserted-by":"crossref","first-page":"15715","DOI":"10.1002\/anie.201507533","article-title":"Sequential in vitro cyclization by cytochrome P450 enzymes of glycopeptide antibiotic precursors bearing the X-domain from nonribosomal peptide biosynthesis","volume":"54","author":"Brieke","year":"2015","journal-title":"Angew. Chem. Int. Ed"},{"key":"10.1074\/jbc.REV119.006349_bib32","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1038\/s41467-019-10384-w","article-title":"Kistamicin biosynthesis reveals the biosynthetic requirements for production of highly crosslinked glycopeptide antibiotics","volume":"10","author":"Greule","year":"2019","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.REV119.006349_bib33","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.chembiol.2007.08.014","article-title":"The biosynthesis of teicoplanin-type glycopeptide antibiotics: assignment of P450 mono-oxygenases to side chain cyclizations of glycopeptide A47934","volume":"14","author":"Hadatsch","year":"2007","journal-title":"Chem. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib34","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/1521-3773(20010504)40:9<1693::AID-ANIE16930>3.0.CO;2-8","article-title":"The biosynthesis of vancomycin-type glycopeptide antibiotics-new insights into the cyclization steps","volume":"40","author":"Bischoff","year":"2001","journal-title":"Angew. Chem. Int. Ed"},{"key":"10.1074\/jbc.REV119.006349_bib35","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1002\/1521-3773(20011217)40:24<4688::AID-ANIE4688>3.0.CO;2-M","article-title":"The biosynthesis of vancomycin-type glycopeptide antibiotics\u2013the order of the cyclization steps","volume":"40","author":"Bischoff","year":"2001","journal-title":"Angew. Chem. Int. Ed"},{"key":"10.1074\/jbc.REV119.006349_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/acschembio.7b00943","article-title":"The thioesterase domain in glycopeptide antibiotic biosynthesis is selective for cross-linked aglycones","volume":"13","author":"Peschke","year":"2018","journal-title":"ACS Chem. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1039\/C8SC03530J","article-title":"The biosynthetic implications of late-stage condensation domain selectivity during glycopeptide antibiotic biosynthesis","volume":"10","author":"Schoppet","year":"2019","journal-title":"Chem. Sci"},{"key":"10.1074\/jbc.REV119.006349_bib38","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jmb.2009.02.010","article-title":"Catalytic turnover-based phage selection for engineering the substrate specificity of Sfp phosphopantetheinyl transferase","volume":"387","author":"Sunbul","year":"2009","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib39","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1039\/C7CC09409D","article-title":"A route to diastereomerically pure phenylglycine thioester peptides: crucial intermediates for investigating glycopeptide antibiotic biosynthesis","volume":"54","author":"Tailhades","year":"2018","journal-title":"Chem. Commun"},{"key":"10.1074\/jbc.REV119.006349_bib40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10295-017-1999-8","article-title":"Synthetic biology, genome mining, and combinatorial biosynthesis of NRPS-derived antibiotics: a perspective","volume":"45","author":"Baltz","year":"2018","journal-title":"J. Ind. Microbiol. Biotechnol"},{"key":"10.1074\/jbc.REV119.006349_bib41","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/sb3000673","article-title":"Combinatorial biosynthesis of cyclic lipopeptide antibiotics: a model for synthetic biology to accelerate the evolution of secondary metabolite biosynthetic pathways","volume":"3","author":"Baltz","year":"2014","journal-title":"ACS Synth. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib42","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1002\/anie.201802856","article-title":"In vitro reconstitution of OxyC activity enables total chemoenzymatic syntheses of vancomycin aglycone variants","volume":"57","author":"Forneris","year":"2018","journal-title":"Angew. Chem. Int. Ed"},{"key":"10.1074\/jbc.REV119.006349_bib43","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1021\/acs.joc.8b00418","article-title":"Precursor manipulation in glycopeptide antibiotic biosynthesis: are \u03b2-amino acids compatible with the oxidative cyclization cascade?","volume":"83","author":"Schoppet","year":"2018","journal-title":"J. Org. Chem"},{"key":"10.1074\/jbc.REV119.006349_bib44","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1021\/acs.orglett.9b03245","article-title":"Enzymatic cascade to evaluate the tricyclization of glycopeptide antibiotic precursor peptides as a prequel to biosynthetic redesign","volume":"21","author":"Tailhades","year":"2019","journal-title":"Org. Lett"},{"key":"10.1074\/jbc.REV119.006349_bib45","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1016\/j.bmcl.2013.06.080","article-title":"Investigation into the functional impact of the vancomycin C-ring aryl chloride","volume":"23","author":"Pinchman","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1074\/jbc.REV119.006349_bib46","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1021\/jm4004494","article-title":"Probing the role of the vancomycin E-ring aryl chloride: selective divergent synthesis and evaluation of alternatively substituted E-ring analogs","volume":"56","author":"Pinchman","year":"2013","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.REV119.006349_bib47","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bmcl.2015.12.027","article-title":"A stepwise dechlorination\/cross-coupling strategy to diversify the vancomycin 'in-chloride'","volume":"26","author":"Wadzinski","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1074\/jbc.REV119.006349_bib48","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1021\/jm9017543","article-title":"Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria","volume":"53","author":"Nakama","year":"2010","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.REV119.006349_bib49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/ja00054a033","article-title":"The role of the sugar and chlorine substituents in the dimerization of vancomycin antibiotics","volume":"115","author":"Gerhard","year":"1993","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib50","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/jo00359a023","article-title":"Iodination of vancomycin, ristocetin A, and ristocetin pseudoaglycon","volume":"51","author":"Harris","year":"1986","journal-title":"J. Org. Chem"},{"key":"10.1074\/jbc.REV119.006349_bib51","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.7164\/antibiotics.49.1236","article-title":"Synthesis and antibacterial activity of derivatives of the glycopeptide antibiotic A-40926 and its Aglycone","volume":"49","author":"Hermann","year":"1996","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.REV119.006349_bib52","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1021\/ja301566t","article-title":"Site-selective bromination of vancomycin","volume":"134","author":"Pathak","year":"2012","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib53","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1021\/ja302692j","article-title":"Catalytic site-selective thiocarbonylations and deoxygenations of vancomycin reveal hydroxyl-dependent conformational effects","volume":"134","author":"Fowler","year":"2012","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib54","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.1021\/ja4038998","article-title":"Chemical tailoring of teicoplanin with site-selective reactions","volume":"135","author":"Pathak","year":"2013","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-5521(02)00101-1","article-title":"Glycopeptide biosynthesis in Amycolatopsis mediterranei DSM5908. Function of a halogenase and a haloperoxidase\/perhydrolase","volume":"9","author":"Puk","year":"2002","journal-title":"Chem. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib56","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1002\/1521-3773(20020916)41:18<3383::AID-ANIE3383>3.0.CO;2-R","article-title":"Fluorobalhimycin\u2013a new chapter in glycopeptide antibiotic research","volume":"41","author":"Weist","year":"2002","journal-title":"Angew. Chem. Int. Ed"},{"key":"10.1074\/jbc.REV119.006349_bib57","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1128\/JB.186.18.6093-6100.2004","article-title":"Biosynthesis of chloro-\u03b2-hydroxytyrosine, a nonproteinogenic amino acid of the peptidic backbone of glycopeptide antibiotics","volume":"186","author":"Puk","year":"2004","journal-title":"J. Bacteriol"},{"key":"10.1074\/jbc.REV119.006349_bib58","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1039\/C7SC00460E","article-title":"Halogenation of glycopeptide antibiotics occurs at the amino acid level during non-ribosomal peptide synthesis","volume":"8","author":"Kittil\u00e4","year":"2017","journal-title":"Chem. Sci"},{"key":"10.1074\/jbc.REV119.006349_bib59","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cbic.200300619","article-title":"Bromobalhimycin and chlorobromobalhimycins\u2013illuminating the potential of halogenases in glycopeptide antibiotic Biosyntheses","volume":"4","author":"Bister","year":"2003","journal-title":"ChemBioChem"},{"key":"10.1074\/jbc.REV119.006349_bib60","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/acsinfecdis.7b00258","article-title":"Developments in glycopeptide antibiotics","volume":"4","author":"Blaskovich","year":"2018","journal-title":"ACS Infect. Dis"},{"key":"10.1074\/jbc.REV119.006349_bib61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41467-017-02123-w","article-title":"Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria","volume":"9","author":"Blaskovich","year":"2018","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.REV119.006349_bib62","doi-asserted-by":"crossref","first-page":"16140","DOI":"10.1021\/jacs.8b08711","article-title":"A dual-function antibiotic-transporter conjugate exhibits superior activity in sterilizing MRSA biofilms and killing persister cells","volume":"140","author":"Antonoplis","year":"2018","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib63","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1021\/acschembio.9b00565","article-title":"Vancomycin\u2013arginine conjugate inhibits growth of carbapenem-resistant E. coli and targets cell-wall synthesis","volume":"14","author":"Antonoplis","year":"2019","journal-title":"ACS Chem. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jac\/dki005","article-title":"Origin, structures, and activity in vitro and in vivo of dalbavancin","volume":"55","author":"Malabarba","year":"2005","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1074\/jbc.REV119.006349_bib65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41557-018-0154-0","article-title":"A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins","volume":"11","author":"Cohen","year":"2019","journal-title":"Nat. Chem"},{"key":"10.1074\/jbc.REV119.006349_bib66","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1021\/ja0499389","article-title":"Mutasynthesis of glycopeptide antibiotics: variations of vancomycin\u2019s AB-ring amino acid 3,5-dihydroxyphenylglycine","volume":"126","author":"Weist","year":"2004","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib67","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cbic.200400328","article-title":"The biosynthesis of vancomycin-type glycopeptide antibiotics\u2013a model for oxidative side-chain cross-linking by oxygenases coupled to the action of peptide synthetases","volume":"6","author":"Bischoff","year":"2005","journal-title":"Chembiochem"},{"key":"10.1074\/jbc.REV119.006349_bib68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/np50061a033","article-title":"Biotransformation of vancomycin B to vancomycin hexapeptide by a soil microorganism","volume":"52","author":"Zmijewski","year":"1989","journal-title":"J. Nat. Prod"},{"key":"10.1074\/jbc.REV119.006349_bib69","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1039\/c39870001694","article-title":"The Edman degradation of vancomycin: preparation of vancomycin hexapeptide","author":"Booth","year":"1987","journal-title":"J. Chem. Soc. Chem. Commun"},{"key":"10.1074\/jbc.REV119.006349_bib70","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1039\/p19890002335","article-title":"Preparation and conformational analysis of vancomycin hexapeptide and aglucovancomycin hexapeptide","volume":"1989","author":"Booth","year":"1989","journal-title":"J. Chem. Soc., Perkin Trans. 1"},{"key":"10.1074\/jbc.REV119.006349_bib71","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1021\/jm801549b","article-title":"Synthesis and evaluation of vancomycin aglycon analogs that bear modifications in the N-terminal d-leucyl amino acid","volume":"52","author":"Crane","year":"2009","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.REV119.006349_bib72","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nbt.2685","article-title":"Identifying producers of antibacterial compounds by screening for antibiotic resistance","volume":"31","author":"Thaker","year":"2013","journal-title":"Nat. Biotech"},{"key":"10.1074\/jbc.REV119.006349_bib73","doi-asserted-by":"crossref","first-page":"13679","DOI":"10.1039\/C6CC06975D","article-title":"Catalytic promiscuity of glycopeptide N-methyltransferases enables bio-orthogonal labelling of biosynthetic intermediates","volume":"52","author":"Brieke","year":"2016","journal-title":"Chem. Commun"},{"key":"10.1074\/jbc.REV119.006349_bib74","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0960-894X(02)00130-0","article-title":"Synthesis and evaluation of vancomycin and vancomycin aglycon analogs that bear modifications in the residue 3 asparagine","volume":"12","author":"McAtee","year":"2002","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1074\/jbc.REV119.006349_bib75","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7164\/antibiotics.52.319","article-title":"Chemical modification of antibiotic eremomycin at the asparagine side chain","volume":"52","author":"Olsufyeya","year":"1999","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.REV119.006349_bib76","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/acsinfecdis.6b00105","article-title":"How to make a glycopeptide: a synthetic biology approach to expand antibiotic chemical diversity","volume":"2","author":"Yim","year":"2016","journal-title":"ACS Infect. Dis"},{"key":"10.1074\/jbc.REV119.006349_bib77","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1093\/cid\/cir920","article-title":"Oritavancin: mechanism of action","volume":"54","author":"Zhanel","year":"2012","journal-title":"Clin. Infect. Dis"},{"key":"10.1074\/jbc.REV119.006349_bib78","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3051","article-title":"Telavancin","volume":"8","author":"Corey","year":"2009","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.REV119.006349_bib79","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7164\/antibiotics.49.575","article-title":"Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity","volume":"49","author":"Cooper","year":"1996","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.REV119.006349_bib80","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7164\/antibiotics.50.509","article-title":"A new type of chemical modification of glycopeptides antibiotics: aminomethylated derivatives of eremomycin and their antibacterial activity","volume":"50","author":"Pavlov","year":"1997","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.REV119.006349_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-016-0103-4","article-title":"Oritavancin: a new lipoglycopeptide antibiotic in the treatment of Gram-positive infections","volume":"5","author":"Brade","year":"2016","journal-title":"Infect Dis. Ther"},{"key":"10.1074\/jbc.REV119.006349_bib82","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jmb.2009.06.064","article-title":"Vancomycin and oritavancin have different modes of action in Enterococcus faecium","volume":"392","author":"Patti","year":"2009","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib83","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/bi010050w","article-title":"Tandem action of glycosyltransferases in the maturation of vancomycin and teicoplanin aglycones: novel glycopeptides","volume":"40","author":"Losey","year":"2001","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.REV119.006349_bib84","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S1074-5521(02)00270-3","article-title":"Incorporation of glucose analogs by GtfE and GtfD from the vancomycin biosynthetic pathway to generate variant glycopeptides","volume":"9","author":"Losey","year":"2002","journal-title":"Chem. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib85","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/nbt909","article-title":"Antibiotic optimization via in vitro glyco-randomization","volume":"21","author":"Fu","year":"2003","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/jbc.REV119.006349_bib86","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.1130028","article-title":"Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions","volume":"313","author":"Zhang","year":"2006","journal-title":"Science"},{"key":"10.1074\/jbc.REV119.006349_bib87","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1002\/1521-3765(20010903)7:17<3798::AID-CHEM3798>3.0.CO;2-6","article-title":"Solid- and solution-phase synthesis of vancomycin and vancomycin analogs with activity against vancomycin-resistant bacteria","volume":"7","author":"Nicolaou","year":"2001","journal-title":"Chem. Eur. J"},{"key":"10.1074\/jbc.REV119.006349_bib88","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41586-019-1589-1","article-title":"Modular click chemistry libraries for functional screens using a diazotizing reagent","volume":"574","author":"Meng","year":"2019","journal-title":"Nature"},{"key":"10.1074\/jbc.REV119.006349_bib89","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1021\/ja406067v","article-title":"Asymmetric catalysis at a distance: catalytic, site-selective phosphorylation of teicoplanin","volume":"135","author":"Han","year":"2013","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.REV119.006349_bib90","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1021\/jm501872s","article-title":"Structure diversification of vancomycin through peptide-catalyzed, site-selective lipidation: a catalysis-based approach to combat glycopeptide-resistant pathogens","volume":"58","author":"Yoganathan","year":"2015","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.REV119.006349_bib91","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1021\/acschembio.9b00050","article-title":"Toward single-peak dalbavancin analogs through biology and chemistry","volume":"14","author":"Alt","year":"2019","journal-title":"ACS Chem. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib92","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nchembio.556","article-title":"Interception of teicoplanin oxidation intermediates yields new antimicrobial scaffolds","volume":"7","author":"Liu","year":"2011","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.REV119.006349_bib93","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1021\/ol201184b","article-title":"Cu(I)- and Ru(II)-mediated \u201cClick\u201d cyclization of tripeptides toward vancomycin-inspired mimics","volume":"13","author":"Zhang","year":"2011","journal-title":"Org. Lett"},{"key":"10.1074\/jbc.REV119.006349_bib94","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1039\/c3cc40628h","article-title":"Synthesis of 1,5-triazole bridged vancomycin CDE-ring bicyclic mimics using RuAAC macrocyclization","volume":"49","author":"Zhang","year":"2013","journal-title":"Chem. Commun"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820304270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820304270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.REV119.006349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:02:42Z","timestamp":1641268962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820304270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":94,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0021925820304270"],"URL":"https:\/\/doi.org\/10.1074\/jbc.rev119.006349","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological, chemical, and biochemical strategies for modifying glycopeptide antibiotics","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.REV119.006349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Marschall.","name":"copyright","label":"Copyright"}]}}